VOQOZON-20 Tablets

Vonoprazan Fumarate 20mg Tablets

LONG-TERM USE OF PPIS MAY CAUSE SOME ADVERSE REACTIONS, SUCH AS MALNUTRITION, INTESTINAL INFECTION AND FRACTURES, SO FINDING SAFE & EFFECTIVE ALTERNATIVE DRUGS IS OF GREAT SIGNIFICANCE

AFTER 30 YEARS OF PPIS

FIRST-IN-CLASS PCABS Potassium Competitive Acid Blockers IS HERE

Current Gastroenterology Reports, 12, 448-457.

A REVOLUTIONARY MEDICATION THAT HAS TRANSFORMED THE TREATMENT OF ACID-RELATED DISORDERS

Vonoprazan fumarate is a novel potassium-competitive acid blocker (P-CAB)

Mainly works by competitively binding to the H+/K+-ATPase on gastric acid-secreting cells, preventing hydrogen ions from entering the gastric cavity, thereby inhibiting gastric acid secretion

Alimentary Phongy & Theses, 42, 710-730

Compared with proton pump inhibitors, it has a faster onset of action, stronger acid suppression, and a longer duration of action

Alimentary Pharmacology & Therapeutks. 41.636-648

As not being affected by the physiological rhythm of gastric acid secretion, it can be administered at any time, without being limited to before or after meals

Theraputic Advances in Gastroenterokee 10, 439-451

Due to longer half-life of vonoprazan, its efficacy lasts for a period of time, helping to reduce the daily dosage.

Alimentary Pharmacology & Therapeutks, 41 636-640

Packing: 10x10

DOSAGE ADMINISTRATION:

GERD & PEPTIC ULCERS:

20 mg once daily.

H. PYLORI ERADICATION

(as part of combination therapy): 20 mg twice daily in combination with antibiotics

Indication:

HYPERACIDITY

REFLUX ESOPHAGITIS

ACID-RELATED DISORDERS

20 ACTS FASTER LASTS LONGER